Mass screening of prostate cancer in Changchun City of China

By Li Xiaomeng   Tsuji Itiro   Kuwahara Masaaki   Zhang Haifeng   Wang Hongliang   Zhang Ling   Ji Guoyi   Zhao Xuejian  

International Urology and Nephrology, Vol. 36, Iss. 4, 2004-12 ,pp. : 541-548

Springer Publishing Company

Access to resources Recommend Favorite

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria 1

By Bartsch G.   Horninger W.   Klocker H.   Reissigl A.   Oberaigner W.   Schonitzer D.   Severi G.   Robertson C.   Boyle P.   the Tyrol Prostate Cancer Screening Group  

Urology, Vol. 58, Iss. 3, 2001-09 ,pp. : 417-424

Elsevier

Access to resources Recommend Favorite

Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: evaluation of mass screening populations

By Ito K.   Kubota Y.   Suzuki K.   Shimizu N.   Fukabori Y.   Kurokawa K.   Imai K.   Yamanaka H.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 705-709

Elsevier

Access to resources Recommend Favorite

High accuracy of Swedish death certificates in men participating in screening for prostate cancer: A comparative study of official death certificates with a cause of death committee using a standardized algorithm

By Godtman Rebecka   Holmberg Erik   Stranne Johan   Hugosson Jonas  

Scandinavian Journal of Urology and Nephrology, Vol. 45, Iss. 4, 2011-09 ,pp. : 226-232

Informa Healthcare

Access to resources Recommend Favorite

Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer:results of a large screening study

By Reissigl A.   Pointner J.   Horninger W.   Ennemoser O.   Strasser H.   Klocker H.   Bartsch G.  

Urology, Vol. 46, Iss. 5, 1995-11 ,pp. : 662-665

Elsevier

Access to resources Recommend Favorite